Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Non-viral gene therapy is being considered as a treatment for cystic fibrosis. In clinical studies and in studies using the mouse airways as a model, current formulations result in only transient transgene expression. A number of reasons for this have been proposed including the loss of plasmid DNA from cells. The aim of these studies was to investigate why transgene expression from non-viral vectors is transient in the mouse lung. Plasmid DNA encoding the luciferase reporter gene was complexed with the cationic lipid GL67 and delivered to the mouse airways. The persistence of plasmid DNA in the mouse lungs was investigated using quantitative PCR and Southern hybridization. Results showed that intact plasmid DNA persisted in the mouse lung in the absence of any detectable luciferase activity. The de novo methylation of plasmid DNA in vivo was investigated as a potential cause of this transient gene expression but results suggested that plasmid DNA does not become de novo methylated in the mouse lung. Therefore processes other than the loss of plasmid DNA from the lung or the de novo methylation of plasmid DNA vectors must be responsible for the transient transgene expression.

Original publication

DOI

10.1038/sj.gt.3302518

Type

Journal article

Journal

Gene Ther

Publication Date

08/2005

Volume

12

Pages

1206 - 1214

Keywords

Adenoviridae, Administration, Inhalation, Animals, Base Sequence, Blotting, Southern, Bronchoalveolar Lavage Fluid, Cystic Fibrosis, DNA, DNA Methylation, Gene Expression, Genes, Reporter, Genetic Therapy, Liposomes, Luciferases, Lung, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Plasmids, Polymerase Chain Reaction, Time Factors, Transfection, Transgenes